fbpx
February 16, 2021

FDA OKs Shockwave Intravascular Lithotripsy for Coronary Plaque FDA OKs Shockwave Intravascular Lithotripsy for Coronary Plaque

Shockwave Medical’s Intravascular Lithotripsy (IVL) system has received premarket approval from the US Food and Drug Administration (FDA) to treat severely calcified coronary artery disease, the […]
February 15, 2021

First Drug That Protects Against Chemo-Induced Myelosuppression First Drug That Protects Against Chemo-Induced Myelosuppression

A novel drug that offers multilineage protection from chemotherapy-induced myelosuppression has been approved by the US Food and Drug Administration. The drug, trilaciclib (Cosela, G1 Therapeutics) […]
February 11, 2021

FDA Approves Orphan Drug Evinacumab-dgnb for Homozygous FH FDA Approves Orphan Drug Evinacumab-dgnb for Homozygous FH

The US Food and Drug Administration has approved the fully human monoclonal antibody evinacumab-dgnb (Evkeeza, Regeneron Pharmaceuticals) for use on top of other cholesterol-modifying meds in […]
February 11, 2021

2021 ACIP Adult Schedule Released 2021 ACIP Adult Schedule Released

The Advisory Committee on Immunization Practices (ACIP) of the Centers for Disease Control and Prevention (CDC) has updated its recommended immunization schedule for adults for 2021. […]
February 11, 2021

ACIP Releases 2021 Child/Adolescent Vaccine Schedule ACIP Releases 2021 Child/Adolescent Vaccine Schedule

The Centers for Disease Control and Prevention (CDC) today released the 2021 Childhood and Adolescent Immunization Schedule. It includes relatively few changes from last year’s schedule […]
February 10, 2021

Cemiplimab Now Approved for Basal Cell Carcinoma Cemiplimab Now Approved for Basal Cell Carcinoma

The Food and Drug Administration has approved cemiplimab-rwlc (Libtayo) as the first immunotherapy to treat patients with locally advanced or metastatic basal cell carcinoma (BCC) previously […]
February 10, 2021

FDA Grants Emergency Use to Monoclonal Antibody Combo for COVID FDA Grants Emergency Use to Monoclonal Antibody Combo for COVID

Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. The US Food and Drug Administration (FDA) has granted emergency use authorization (EUA) to two […]
February 8, 2021

FDA Clears Novel Daytime Device for Obstructive Sleep Apnea FDA Clears Novel Daytime Device for Obstructive Sleep Apnea

The US Food and Drug Administration (FDA) has approved the first device to help reduce snoring and mild obstructive sleep apnea (OSA) that is used during […]
February 6, 2021

FDA OKs New CAR T- Cell Tx for Large B-cell Lymphomas FDA OKs New CAR T- Cell Tx for Large B-cell Lymphomas

The US Food and Drug Administration (FDA) has approved lisocabtagene maraleucel (Breyanzi), a chimeric antigen receptor (CAR) T-cell product for the treatment of adults with certain […]
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0